Items where Division is "Medicine > Abteilung für Nuklearmedizin" and Year is 2017
![]() | Up a level |
B
Bauer, Johann and Kopp, Sascha and Schlagberger, Elisabeth Maria and Grosse, Jirka and Sahana, Jayashree and Riwaldt, Stefan and Wehland, Markus and Luetzenberg, Ronald and Infanger, Manfred and Grimm, Daniela (2017) Proteome Analysis of Human Follicular Thyroid Cancer Cells Exposed to the Random Positioning Machine. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 18 (3): 546. ISSN 1422-0067
H
Hellwig, Dirk and Marienhagen, Joerg and Menhart, Karin and Grosse, Jirka (2017) Nuklearmedizin in Deutschland. NUKLEARMEDIZIN-NUCLEAR MEDICINE, 56 (2). pp. 55-68. ISSN 0029-5566
Hutterer, Markus and Ebner, Yvonne and Riemenschneider, Markus J. and Willuweit, Antje and McCoy, Mark and Egger, Barbara and Schroeder, Michael and Wendl, Christina and Hellwig, Dirk and Grosse, Jirka and Menhart, Karin and Proescholdt, Martin and Fritsch, Brita and Urbach, Horst and Stockhammer, Guenther and Roelcke, Ulrich and Galldiks, Norbert and Meyer, Philipp T. and Langen, Karl-Josef and Hau, Peter and Trinka, Eugen (2017) Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by F-18-Fluoroethyl-L-Tyrosine Amino Acid PET: A Potential Brain Tumor Mimic. JOURNAL OF NUCLEAR MEDICINE, 58 (1). pp. 129-137. ISSN 0161-5505, 1535-5667
P
Pfreundschuh, M. and Christofyllakis, K. and Altmann, B. and Ziepert, M. and Haenel, M. and Viardot, A. and Neubauer, A. and Held, G. and Truemper, L. and Schmidt, C. and Kanz, L. and Hallek, M. and Schmitz, N. and Heintges, T. and Koelbel, C. and Schneider, G. and Ruebe, C. and Hellwig, D. and Poeschel, V. and Murawski, N. (2017) Radiotherapy to bulky disease PET-negative after immunochemotherapy can be spared in elderly DLBCL patients: results of a planned interim analysis of the first 187 patients with bulky disease treated in the OPTIMAL > 60 study of the DSHNHL. KARGER, BASEL.
S
Schmidbauer, Benedikt and Menhart, Karin and Hellwig, Dirk and Grosse, Jirka (2017) Differentiated Thyroid Cancer-Treatment: State of the Art. MDPI, BASEL.

